Diagnostic options · UAE

Tumor Profiling tests in Dubai & UAE

Compare available Tumor Profiling tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

16,000.00–65,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Tumor Profiling test prices

Showing 1–3 of 3 matching tests.

Tumor Profiling diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2539 MI (Molecular Intelligence) Profile Test This diagnostic test evaluates archival tumor tissue using NGS and IHC to identify actionable genomic alterations and protein expression patterns relevant to cancer treatment.	Archival Tissue Specimen (FFPE Block or Slides)	35 Working Days	65,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Cancer-related gene mutations (DNA)", "Gene expression levels (RNA)", "Protein expression (IHC)"] Parameters [] Preparation ["No fasting required", "Ensure completed Tumor Profiling Requisition Form (Form 47) and original histopathology report accompany the sample"] Indications ["Diagnosis of cancer", "Identification of targeted therapy options", "Clinical trial matching", "Personalized oncology treatment planning"] Measurement technique Confirm with laboratory Codes LOINC: 86247-5 ICD-10: C80.1, Z15.09, Z12.8 Clinical summary This diagnostic test evaluates archival tumor tissue using NGS and IHC to identify actionable genomic alterations and protein expression patterns relevant to cancer treatment.
TEST-2534 Molecular Intelligence Tumor Seek Test This test performs comprehensive genomic profiling on FFPE tumor tissue to identify actionable genetic alterations for personalized cancer therapy.	FFPE Tumor Tissue Block (Archival Specimen)	30 Working Days	52,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DNA mutations", "RNA fusions", "Splice variants", "Gene expression levels", "Over 500 cancer-related genes"] Parameters [] Preparation [] Indications ["Patients with solid tumors where targeted therapy is being considered.", "Identification of actionable genetic alterations.", "Guidance for personalized cancer treatment."] Measurement technique Confirm with laboratory Codes LOINC: 98590-2 ICD-10: C80.1 Clinical summary This test performs comprehensive genomic profiling on FFPE tumor tissue to identify actionable genetic alterations for personalized cancer therapy.
TEST-1267 Oncomine Comprehensive Panel + Tumor Mutation Burden (TMB) + Microsatellite Instability (MSI) + PD-L1 (IHC) Test This test evaluates hundreds of cancer-related genes, tumor mutational burden, microsatellite instability, and PD-L1 expression using NGS and IHC.	Tumor tissue (formalin-fixed paraffin-embedded block or unstained slides) and peripheral whole blood	14–21 business days	16,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Somatic mutations in >500 genes", "Tumor Mutation Burden (TMB)", "Microsatellite Instability (MSI)", "PD-L1 expression (IHC)"] Parameters [{"name": "Tumor Mutation Burden (TMB)", "reference_range": null}, {"name": "Microsatellite Instability (MSI)", "reference_range": null}, {"name": "PD-L1 Expression", "reference_range": null}, {"name": "Somatic Mutations", "reference_range": null}] Preparation ["A valid prescription from a DHA-licensed physician is required.", "Ensure sufficient tumor tissue is available."] Indications ["Guiding targeted therapy selection", "Determining immunotherapy eligibility", "Assessing hereditary cancer risk", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 101661-5 ICD-10: Z15.09, Z15.01, Z15.02 Clinical summary This test evaluates hundreds of cancer-related genes, tumor mutational burden, microsatellite instability, and PD-L1 expression using NGS and IHC.

Category overview

Tumor Profiling: overview

Understanding the broader molecular landscape of a malignancy brings ultimate peace of mind and empowers you to make proactive, targeted healthcare decisions. Situated within our Molecular Diagnostics division, our comprehensive Tumor Profiling testing leverages high-throughput next-generation sequencing to evaluate expansive networks of cancer-related DNA and RNA. Rather than making a definitive standalone diagnosis, this deeply detailed genomic data provides your oncologist with the molecular foundational insights required to tailor highly customized, preventive medical guidance and precision therapies. Renowned as a leading choice among diagnostic labs in Dubai and the UAE, DNA Labs UAE guarantees uncompromising patient confidentiality and consistently fast, accurate results. Step confidently into personalized oncology care: review our tumor profiling testing in the UAE below to book an appointment, schedule a convenient home collection, or contact our medical team.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.